The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

FDA insistence that companies must undertake long-term cardiovascular outcomes trials is transforming the type 2 diabetes market, and Boehringer Ingelheim and Lilly’s Jardiance pill now looks ...

The serious health condition affected around 14 percent of all adults worldwide in 2022, compared to seven percent in 1990, ...

The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Type 1 Diabetes market has been expanding significantly in recent years ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Dublin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Care Nutrition Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application" report has ...

Report on how AI is redefining market landscape - The global gastroparesis drugs market size is estimated to grow by USD 1.42 ...

Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and diabetes drugs but cannot ...